By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) Closes $31 Million Financing 10/9/2014 9:02:44 AM
LifeMap Sciences Announces Release And Commercial Availability Of Geneanalytics™ 1.0, A Powerful Gene Set Analysis Tool Powered By Genecards®, Lifemap Discovery® And Malacards 10/6/2014 9:09:07 AM
LifeMap Sciences, A Subsidiary Of BioTime (BTX), Announces Release Of Malacards Version 1.06 With Greatly Improved Gene-Disease Associations 10/6/2014 9:02:30 AM
BioTime (BTX) And Subsidiaries To Raise $31 Million Through Sales Of Common Shares 10/6/2014 8:57:17 AM
Michael H. Mulroy And Stephen L. Cartt Joining BioTime (BTX) Board Of Directors 10/6/2014 8:31:06 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation Announces Completion Of Multi-Site Clinical Study Of Lung Cancer Diagnostic By Collaborators At The Wistar Institute 10/3/2014 7:30:26 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation's CEO Dr. Joseph Wagner To Present At BTIG’s Inaugural “Emerging Technologies In Healthcare Diagnostics” Symposium 9/19/2014 8:28:40 AM
BioTime (BTX) Announces Presentation Of Phase 3 Data At EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 9/19/2014 7:23:10 AM
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates The Safety And Efficacy Of Opregen® In Preclinical Animal Studies 9/17/2014 11:02:24 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation And Abcodia To Collaborate On Breast Cancer Diagnostic Development 9/15/2014 11:00:54 AM